Search Results
Found 1 results
510(k) Data Aggregation
(207 days)
ANGIODYNAMICS ANGIOSTENT BILIARY STENT SYSTEM
The ANGIODYNAMICS ANGIOSTENT Biliary Stent System is indicated for palliative treatment of malignant strictures in the biliary tree.
Not Found
The provided document, a 510(k) premarket notification letter from the FDA for the AngioDynamics AngioStent Biliary Stent System, does not contain the information requested in your prompt regarding acceptance criteria, device performance results, or details of a study proving the device meets acceptance criteria.
This letter is a regulatory document confirming that the device is substantially equivalent to a legally marketed predicate device and can proceed to market, provided certain labeling limitations are met. It discusses regulatory classifications, general controls, and labeling requirements.
Therefore, I cannot populate the requested table or answer the specific questions about sample sizes, ground truth, expert qualifications, adjudication methods, MRMC studies, or standalone performance based on this document. The document's purpose is to grant market clearance, not to present a detailed study report.
Ask a specific question about this device
Page 1 of 1